Oligonucleotides-A Novel Promising Therapeutic Option for IBD by Patrizio Scarozza, Patrizio Scarozza, Heike Schmitt, Giovanni Monteleone, Markus F. Neurath, Raja Atreya

Connect to this object online.

Ileal and colonic Crohn's disease: Does location makes a difference in therapy efficacy? by Raja Atreya, Christian Bojarski, Anja A. Kühl, Zlatko Trajanoski, Markus F. Neurath, Britta Siegmund

Connect to this object online.

Add-on multiple submucosal injections of the RNA oligonucleotide GUT-1 to anti-TNF antibody treatment in patients with moderate-to-severe ulcerative colitis: an open-label, proof-o... by Kenji Suzuki, Yukinori Sameshima, Junji Yokoyama, Shuji Terai, Hiroyuki Yoneyama, Raja Atreya, Markus F. Neurath, Toshifumi Hibi, Hitoshi Asakura

Connect to this object online.

Review and Analysis of German Mobile Apps for Inflammatory Bowel Disease Management Using the Mobile Application Rating Scale: Systematic Search in App Stores and Content Analysis by Maximilian Gerner, Nicolas Vuillerme, Timothée Aubourg, Eva-Maria Messner, Yannik Terhorst, Verena Hörmann, Ingo Ganzleben, Hannah Schenker, Georg Schett, Raja Atreya, Markus F Neurath, Johannes Knitza, Till Orlemann

Connect to this object online.

Cellular Mechanisms of Etrolizumab Treatment in Inflammatory Bowel Disease by Charlotte Lichnog, Sha Klabunde, Emily Becker, Franklin Fuh, Philipp Tripal, Raja Atreya, Entcho Klenske, Rich Erickson, Henry Chiu, Chae Reed, Shan Chung, Clemens Neufert, Imke Atreya, Jacqueline McBride, Markus F. Neurath, Sebastian Zundler

Connect to this object online.